Annual CFF:
$71.68M-$130.28M(-64.51%)Summary
- As of today, INBX annual cash from financing is $71.68 million, with the most recent change of -$130.28 million (-64.51%) on December 31, 2024.
- During the last 3 years, INBX annual cash from financing has fallen by -$12.09 million (-14.43%).
- INBX annual cash from financing is now -64.51% below its all-time high of $201.96 million, reached on December 31, 2023.
Performance
INBX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFF:
$352.00K+$352.00K(+100.00%)Summary
- As of today, INBX quarterly cash from financing is $352.00 thousand, with the most recent change of +$352.00 thousand (+100.00%) on September 30, 2025.
- Over the past year, INBX quarterly cash from financing has increased by +$352.00 thousand (+100.00%).
- INBX quarterly cash from financing is now -99.78% below its all-time high of $158.66 million, reached on December 31, 2022.
Performance
INBX Quarterly Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$100.19M+$352.00K(+0.35%)Summary
- As of today, INBX TTM cash from financing is $100.19 million, with the most recent change of +$352.00 thousand (+0.35%) on September 30, 2025.
- Over the past year, INBX TTM cash from financing has increased by +$28.51 million (+39.78%).
- INBX TTM cash from financing is now -61.25% below its all-time high of $258.55 million, reached on December 31, 2022.
Performance
INBX TTM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
INBX Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -64.5% | +100.0% | +39.8% |
| 3Y3 Years | -14.4% | -30.4% | -29.1% |
| 5Y5 Years | +65.4% | -99.7% | -32.8% |
INBX Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -64.5% | at low | -99.8% | >+9999.0% | -61.3% | +153.1% |
| 5Y | 5-Year | -64.5% | +65.4% | -99.8% | >+9999.0% | -61.3% | +153.1% |
| All-Time | All-Time | -64.5% | +444.9% | -99.8% | +109.7% | -61.3% | +5808.9% |
INBX Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $352.00K(>+9900.0%) | $100.19M(+0.4%) |
| Jun 2025 | - | $0.00(-100.0%) | $99.84M(-24.8%) |
| Mar 2025 | - | $99.84M(>+9900.0%) | $132.79M(+85.3%) |
| Dec 2024 | $71.68M(-64.5%) | $0.00(0.0%) | $71.68M(0.0%) |
| Sep 2024 | - | $0.00(-100.0%) | $71.68M(0.0%) |
| Jun 2024 | - | $32.95M(-14.9%) | $71.68M(+81.1%) |
| Mar 2024 | - | $38.73M(+4434.9%) | $39.58M(-75.3%) |
| Dec 2023 | $201.96M(+120.7%) | - | - |
| Jun 2023 | - | $854.00K(+139.9%) | $160.38M(-27.0%) |
| Mar 2023 | - | $356.00K(-99.8%) | $219.68M(-15.0%) |
| Dec 2022 | $91.50M(+9.2%) | $158.66M(>+9900.0%) | $258.55M(+82.9%) |
| Sep 2022 | - | $506.00K(-99.2%) | $141.38M(-0.2%) |
| Jun 2022 | - | $60.16M(+53.4%) | $141.69M(+16.1%) |
| Mar 2022 | - | $39.22M(-5.4%) | $122.00M(+45.6%) |
| Dec 2021 | $83.77M | $41.48M(+4959.0%) | $83.77M(+41.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $820.00K(-98.0%) | $59.28M(-69.5%) |
| Jun 2021 | - | $40.48M(+3996.9%) | $194.68M(+13.8%) |
| Mar 2021 | - | $988.00K(-94.2%) | $171.08M(+2.8%) |
| Dec 2020 | $166.46M(+284.2%) | $17.00M(-87.5%) | $166.46M(+11.7%) |
| Sep 2020 | - | $136.22M(+707.2%) | $149.02M(+1264.9%) |
| Jun 2020 | - | $16.88M(+564.5%) | $10.92M(-63.5%) |
| Mar 2020 | - | -$3.63M(-727.6%) | $29.90M(-31.0%) |
| Dec 2019 | $43.33M(+229.4%) | -$439.00K(+76.7%) | $43.33M(-1.0%) |
| Sep 2019 | - | -$1.89M(-105.3%) | $43.77M(-4.1%) |
| Jun 2019 | - | $35.85M(+266.1%) | $45.65M(+169.6%) |
| Mar 2019 | - | $9.79M(+37.3%) | $16.93M(+214.7%) |
| Dec 2018 | $13.15M(-2.8%) | - | - |
| Jun 2018 | - | $7.13M(+506.6%) | $5.38M(+406.6%) |
| Mar 2018 | - | -$1.75M | -$1.75M |
| Dec 2017 | $13.54M | - | - |
FAQ
- What is Inhibrx Biosciences, Inc. annual cash from financing?
- What is the all-time high annual cash from financing for Inhibrx Biosciences, Inc.?
- What is Inhibrx Biosciences, Inc. annual cash from financing year-on-year change?
- What is Inhibrx Biosciences, Inc. quarterly cash from financing?
- What is the all-time high quarterly cash from financing for Inhibrx Biosciences, Inc.?
- What is Inhibrx Biosciences, Inc. quarterly cash from financing year-on-year change?
- What is Inhibrx Biosciences, Inc. TTM cash from financing?
- What is the all-time high TTM cash from financing for Inhibrx Biosciences, Inc.?
- What is Inhibrx Biosciences, Inc. TTM cash from financing year-on-year change?
What is Inhibrx Biosciences, Inc. annual cash from financing?
The current annual cash from financing of INBX is $71.68M
What is the all-time high annual cash from financing for Inhibrx Biosciences, Inc.?
Inhibrx Biosciences, Inc. all-time high annual cash from financing is $201.96M
What is Inhibrx Biosciences, Inc. annual cash from financing year-on-year change?
Over the past year, INBX annual cash from financing has changed by -$130.28M (-64.51%)
What is Inhibrx Biosciences, Inc. quarterly cash from financing?
The current quarterly cash from financing of INBX is $352.00K
What is the all-time high quarterly cash from financing for Inhibrx Biosciences, Inc.?
Inhibrx Biosciences, Inc. all-time high quarterly cash from financing is $158.66M
What is Inhibrx Biosciences, Inc. quarterly cash from financing year-on-year change?
Over the past year, INBX quarterly cash from financing has changed by +$352.00K (+100.00%)
What is Inhibrx Biosciences, Inc. TTM cash from financing?
The current TTM cash from financing of INBX is $100.19M
What is the all-time high TTM cash from financing for Inhibrx Biosciences, Inc.?
Inhibrx Biosciences, Inc. all-time high TTM cash from financing is $258.55M
What is Inhibrx Biosciences, Inc. TTM cash from financing year-on-year change?
Over the past year, INBX TTM cash from financing has changed by +$28.51M (+39.78%)